Trial of VivaGel in Sexually Active Young Women Commences
Starpharma Holdings Limited announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel(TM)) in sexually active young women. The Microbicide Trials Network (MTN) is leading the study, funded by the U.S. National Institutes of Health (NIH)...Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission
...l company Starpharma saw an 8% increase in its share, following approval of vivagel by the FDA, a new formulation, believed to prevent transmission of HIV. // ...ts for the prevention of HIV infection. The FDA recognizes the potential of vivagel to address this unmet medical need. Vivagel's new drug application will now...Starpharma | Product Pipeline | VivaGel™
Viva Gel is a sexual lubricant with anti-viral properties manufactured by Australian pharmaceutical company Starpharma. It has passed through animal testing phases of the Drug Approval Process in Australia and the United States. Initial human safety tests are to ensue. The NIH and NIAID have awarded grants totaling $25.7 million for VivaGel's continued...A webpage for all about nanopharmaceuticals: nanomedicine ...
potential of VivaGel to address this unmet medical need," commented John Raff, ... the success of the VivaGel development program. ...MICROBICIDE VIVAGEL RECEIVES FAST TRACK STATUS FROM FDA
The FDA recognises the potential of VivaGel to address this unmet medical need, ... This is excellent news for VivaGel and for Starpharma. ...Starpharma Holdings Reports Positive VivaGel(R) Clinical Study Results
... its objectives demonstrating that 3% SPL7013 Gel (VivaGel(R)) was safe and well ... VivaGel(R) is being developed as a topical vaginal microbicide for the ...